The study found that as levels of vitamin D went down, levels of cognitive
impairment went up. …
Author: Hakeem Ali-Bocas Alexander
Drugs from genetically engineered animals poised to debut in U.S. (Medill Reports, Chicago)
“Transgenic animals are probably going to be the drug stores of the future,”
said biologist Bryan Pickett, who works with genetically engineered zebra fish
at Loyola University of Chicago. …
TODAY’S SPOTLIGHT… Vioxx liens cut as lawyers request fee hike (Fierce Biotech)
Vioxx plaintiff lawyers are asking a judge to nullify a cap on their contingency
fees …
More Zyprexa Trouble for Lilly as Insurers Want Money Too (BNET Pharma)
The issue at stake is whether insurance companies can claim even though they
were not the targets of Lilly’s fraud: …
The Overwhelming Evidence That Sunlight Fights Cancer (Mercola.com)
The theory that solar ultraviolet radiation — and by extension, vitamin D,
which is produced when such radiation strikes your skin — is a potent cancer
fighter satisfies most, if not all, of the criteria. From a scientific point of
view, therefore, vitamin D reduces the risk of many forms of cancer and
increases survival rates once cancer reaches a detectable stage.
…
New Survey Shows Many Americans in Control of Their Own Healthcare (Nutraceuticals World)
Supplement users also tend to place an emphasis on health as a priority in their
own personal lives, as reflected in their day-to-day habits when it comes to
maintaining overall wellness. …
Lilly agrees to settle criminal investigation over the psych drug Zyprexa.
As part of the settlement
with the Justice Department, Lilly agreed to plead guilty to one
misdemeanor violation of the Food, Drug and Cosmetic Act related to the
off-label promotion of Zyprexa between 1999 and 2001. The guilty plea
says Lilly promoted the drug in elderly people as treatment for
dementia, including Alzheimer’s, although the drug isn’t approved for
such use.
…
Study Finds Drug Risks With Newer Antipsychotics (New York Times)
They found 478 sudden cardiac deaths among those taking
the drugs, about twice the rate of the control group. The risk —
equivalent to 3 deaths for every 1,000 patients taking the drugs for a
year — was about the same whether people took the newer or older
medications. The higher the dose of the drug, the study found, the
higher the risk of sudden death. …
Lilly to pay $1.4B in Zyprexa settlement
Lilly had been accused of persuading doctors to prescribe Zyprexa to
children and the elderly, despite the fact that the drug wasn’t
FDA-approved for those patient groups–and the knowledge that it was
particularly risky for them to take. As you know, Zyprexa has been
shown to cause excessive weight gain and to boost the risk of death in
elderly patients with dementia. …
Anonymous LA
Los Angeles, United States Socal anonymous has the delightful advantage of being close to Hollywood. Hollywood isn’t all tourists and movie stars; it’s also the […]